UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000032659
Receipt number R000036700
Scientific Title A phase 2 study of KRd(carfilzomib, lenalidomide, dexamethasone) consolidation for newly diagnosed multiple myeloma
Date of disclosure of the study information 2018/05/22
Last modified on 2022/01/27 11:30:13

No. Disposal Last modified on Item of update
1 Insert 2018/05/21 14:59:54
2 Update 2018/05/23 20:13:21 Recruitment status
3 Update 2018/05/24 20:04:32 Organization
Organization
4 Update 2018/07/27 13:49:28 Institutions
5 Update 2018/11/19 21:18:53 Email1
6 Update 2018/11/21 21:41:37 Organization1
Address1
Tel1
Email1
7 Update 2018/11/22 19:43:09 Email1
8 Update 2019/05/22 12:32:33 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
Institutions
9 Update 2019/05/22 12:39:35 Date of IRB
Last follow-up date
10 Update 2019/12/19 20:52:49 Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
11 Update 2019/12/19 21:10:40
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
Target sample size
12 Update 2019/12/19 21:13:13 Last follow-up date
13 Update 2019/12/21 14:49:26 Key inclusion criteria
Key exclusion criteria
14 Update 2021/06/10 10:59:59 Email1
Email
15 Update 2021/07/09 19:47:58 Email1
Email
16 Update 2022/01/27 11:30:13 Recruitment status